Within the framework of the Innovative Health Initiative (IHI), the European Commission has published some interesting calls for proposals, aimed at improving and protecting the health and well-being of citizens. The open calls, which fall under the Horizon Europe programme, are related to cardiovascular disease research and early feasibility studies.

The overall aim of the project is to provide tools for the earlier diagnosis of atherosclerosis and heart failure as well as earlier identification of patients at risk. This includes biomarker or predictive algorithms to assess changes in risk and stratify patients according to individual responses to therapeutic intervention.

The two calls are articulated as follows:

- Cardiovascular diseases – improved prediction, prevention, diagnosis, and monitoring.

- Setting up a hamonised methodology to promote uptake of early feasibility studies for clinical and innovation excellence in the European Union.

The budget provided is 21.9 million €, and the deadlines for subscription are 20th September 2022 (1^st stage) and 28^th February 2023 (2^nd stage). Hereunder you can find an overview table with the links to the project website.

If you are interested in taking part in these calls, we invite you to visit their website by clicking here.